TrainN-Safe MDs Project kicked off - March 15
March 16, 2020
The kick-off meeting of the TrainN-SafeMDs had to originally take place at AIT, Austria on March 16. Due to the COVID-19 situation in the region and restrictions to travel abroad, a teleconference was organised instead. The consortium discussed the scientific and logistic plans and activities related to the dissemination of the project. It was agreed, that web-site will be launched in April to promote the project objectives as well as outputs. The teams will cross-train each other in the established methods and models in the time-frame of 06/2020-12/2020 and it is foreseen that despite current travel restrictions, there will be no delays in fulfilling the project objectives. Data generated in this project in the following year will build a basis for a larger validation project in the area of the medical devices’ safety assessment in the upcoming years.
Web page launch
April 30, 2020
We are excited to announce the launch of TraiN-SafeMDs website that will serve as main communication and dissemination tool for our project. Besides this, a social media accounts (Facebook, Twitter and Linkedin ) have been established to outreach the scientific community and young scientists interested in the development and validation of in vitro methods in the area of medical devices. We hope that our visitors will enjoy our new website, and will find it easy to navigate and informative.
Participation at the TOXCON 2020 Conference
September 06, 2020
Written by CEM
The partners of theTraiN-SafeMDs present the poster related to the launch of the international project SafeTrainMDs at the TOXCON 2020 Conference in Prague and also met to discuss the project schedule that has partly been affected by the COVID-19. The abstract poster can be downloaded here
Invited Lecture - Omics4Health cluster meeting
October 08, 2020
Written by CEM
Dr. Kandarova presented an Invited lecture at the meeting of the scientific cluster Omics4Health (October 8, Hotel Park Inn, Bratislava, Slovakia) on the use of reconstructed human tissue models in toxicology, pharmacology and medical safety testing in the regulatory context of the OECD guidelines and ISO standards. The lecture is available per request.